PARP1 rs1136410 Val762Ala contributes to an increased risk of overall cancer in the East Asian population: a meta-analysis

J Int Med Res. 2021 Mar;49(3):300060521992956. doi: 10.1177/0300060521992956.

Abstract

Objectives: To investigate the association between poly(ADP-ribose) polymerase 1 (PARP1) rs1136410 Val762Ala and cancer risk in Asian populations, as published findings remain controversial.

Methods: The PubMed and EMBASE databases were searched, and references of identified studies and reviews were screened, to find relevant studies. Meta-analyses were performed to evaluate the association between PARP1 rs1136410 Val762Ala and cancer risk, reported as odds ratio (OR) and 95% confidence interval (CI).

Results: A total of 24 studies with 8 926 cases and 15 295 controls were included. Overall, a significant association was found between PARP1 rs1136410 Val762Ala and cancer risk in East Asians (homozygous: OR 1.19, 95% CI 1.06, 1.35; heterozygous: OR 1.10, 95% CI 1.04, 1.17; recessive: OR 1.13, 95% CI 1.02, 1.25; dominant: OR 1.13, 95% CI 1.06, 1.19; and allele comparison: OR 1.09, 95% CI 1.03, 1.15). Stratification analyses by race and cancer type revealed similar results for gastric cancer among the Chinese population.

Conclusion: The findings suggest that PARP1 rs1136410 Val762Ala may be significantly associated with an increased cancer risk in Asians, particularly the Chinese population.

Keywords: PARP1; Val762Ala; cancer; meta-analysis; risk.

Publication types

  • Meta-Analysis

MeSH terms

  • Asian People / genetics
  • Genetic Predisposition to Disease*
  • Humans
  • Neoplasms* / genetics
  • Poly (ADP-Ribose) Polymerase-1* / genetics
  • Polymorphism, Single Nucleotide

Substances

  • PARP1 protein, human
  • Poly (ADP-Ribose) Polymerase-1